| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States
2 Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States
3 Medicine/Cardiovascular Diease, University of Alabama at Birmingham, Birmingham, Alabama, United States
* To whom correspondence should be addressed. E-mail: dqxing{at}uab.edu.
Objective: Inflammation plays a major role in vascular disease. We have shown that leukocyte infiltration and inflammatory mediator expression contribute to vascular remodeling after endoluminal injury. This study tested whether increasing protein O-linked-N-acetylglucosamine (O-GlcNAc) levels with glucosamine (GlcN) and O-2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) inhibits acute inflammatory and neointimal responses to endoluminal arterial injury. Methods and Results: Ovariectomized rats were treated with a single injection of GlcN (0.3 mg g-1, i.p.), PUGNAc (7 nmol g-1, i.p.) or vehicle (V) 2 hrs prior to balloon injury of the right carotid artery. O-GlcNAc-modified protein levels decreased markedly in injured arteries of V treated rats at 30 min, 2 hrs and 24 hrs after injury but returned to control (contralateral uninjured) levels after 14 days. Both GlcN and PUGNAc increased O-GlcNAc modified protein levels in injured arteries compared to V controls at 30 min post injury; the GlcN-mediated increase persisted at 24 hrs but was not evident at 14 days. Proinflammatory mediator expression increased markedly after injury and was reduced significantly (30-50%) by GlcN and PUGNAc. GlcN and PUGNAc also inhibited infiltration of neutrophils and monocytes into injured arteries. Chronic (14 days) treatment with GlcN reduced neointima formation in injured arteries by 50% compared to V controls. Conclusions: Acute GlcN and PUGNAc treatment increases O-GlcNAc modified protein levels and inhibits acute inflammatory responses in balloon injured rat carotid arteries; 14 day GlcN treatment inhibits neointima formation in these vessels. Augmenting O-GlcNAc modification of proteins in the vasculature may represent a novel anti-inflammatory and vasoprotective mechanism.
This article has been cited by other articles:
|
|
 |
|
  R. Largo, M. J. Martinez-Calatrava, O. Sanchez-Pernaute, M. E. Marcos, J. Moreno-Rubio, C. Aparicio, J. Egido, and G. Herrero-Beaumont Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H268 - H276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zou, S. Yang, V. Champattanachai, S. Hu, I. H. Chaudry, R. B. Marchase, and J. C. Chatham Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H515 - H523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Ngoh and S. P. Jones New Insights into Metabolic Signaling and Cell Survival: The Role of {beta}-O-Linkage of N-Acetylglucosamine J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 602 - 609. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
